3.13 Other pharmacological effects In addition to the previously discussed bioactivities, catalpol has been reported to treat a wide range of conditions, including hemorrhage, vitiligo, Sjogrens syndrome, Guillain-Barr syndrome, chronic inflammatory pain, bone marrow suppression, thyroid dysfunction, aging, depression, pancreatitis, demyelination, burns, polycystic ovary syndrome (PCOS), Duchenne muscular dystrophy (DMD), allergic asthma, blood deficiency syndrome, and other diseases
Die Verwendung von BPC-157 bleibt im Rahmen der experimentellen Forschung
The half-life of the No-DAC form (often quoted at about 30 minutes) is based on the DPP-IV-resistant substitutions and secondary sources, not on a dedicated human PK study
This typically happens around week three to five, depending on your tolerance
Long-term controlled trial data specifically for CJC-1295/Ipamorelin is limited
For many of our San Ramon patients, GHK-Cu and retinol are used together as a complementary pair retinol to accelerate turnover, and GHK-Cu to support healing and collagen rebuilding at the same time
